Psychosocial Well-Being and Quality of Life in Uveitis: A Review

References

• Dunn JP. Uveitis. Prim Care. September 2015;42(3):305–23. doi:10.1016/j.pop.2015.05.003.
   PubMed Web of Science ®Google Scholar
• Tomkins-Netzer O, Talat L, Bar A, et al. Long-term clinical outcome and causes of vision loss in patients with uveitis. Ophthalmology. December 2014;121(12):2387–92. doi:10.1016/j.ophtha.2014.07.007.
   PubMed Web of Science ®Google Scholar
• Niederer RL, Sharief L, Bar A, Lightman SL, Tomkins-Netzer O. Predictors of long-term visual outcome in intermediate uveitis. Ophthalmology. March 2017;124(3):393–398. doi:10.1016/j.ophtha.2016.11.013.
   PubMed Web of Science ®Google Scholar
• Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. April 1996;80(4):332–6. doi:10.1136/bjo.80.4.332.
   PubMed Web of Science ®Google Scholar
• Miserocchi E, Fogliato G, Modorati G, Bandello F. Review on the worldwide epidemiology of uveitis. Eur J Ophthalmol. September-October 2013;23(5):705–17. doi:10.5301/ejo.5000278.
   PubMed Web of Science ®Google Scholar
• Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. September 2004;88(9):1159–62. doi:10.1136/bjo.2003.037226.
   PubMed Web of Science ®Google Scholar
• Rosenbaum JT, Bodaghi B, Couto C, et al. New observations and emerging ideas in diagnosis and management of non-infectious uveitis: a review. Semin Arthritis Rheum. December 2019;49(3):438–445. doi:10.1016/j.semarthrit.2019.06.004.
   PubMed Web of Science ®Google Scholar
• Groen F, Ramdas W, de Hoog J, Vingerling JR, Rothova A. Visual outcomes and ocular morbidity of patients with uveitis referred to a tertiary center during first year of follow-up. Eye (Lond). March 2016;30(3):473–80. doi:10.1038/eye.2015.269.
   PubMed Web of Science ®Google Scholar
• Al-Dhibi HA, Al-Mahmood AM, Arevalo JF. A systematic approach to emergencies in uveitis. Middle East Afr J Ophthalmol. July-September 2014;21(3):251–8. doi:10.4103/0974-9233.134687.
   PubMedGoogle Scholar
• Kempen JH, Daniel E, Dunn JP, et al. Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study. Bmj. July 3, 2009;339:b2480. doi:10.1136/bmj.b2480.
   PubMedGoogle Scholar
• Scott IU, Smiddy WE, Schiffman J, Feuer WJ, Pappas CJ. Quality of life of low-vision patients and the impact of low-vision services. Am J Ophthalmol. July, 1999;128(1):54–62. doi:10.1016/s0002-9394(99)00108-7.
   PubMed Web of Science ®Google Scholar
• Stelmack J. Quality of life of low-vision patients and outcomes of low-vision rehabilitation. Optom Vis Sci. May 2001;78(5):335–42. doi:10.1097/00006324-200105000-00017.
   PubMed Web of Science ®Google Scholar
• Langelaan M, de Boer MR, van Nispen RM, Wouters B, Moll AC, van Rens GH. Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions. Ophthalmic Epidemiol. May-June 2007;14(3):119–26. doi:10.1080/09286580601139212.
   PubMed Web of Science ®Google Scholar
• Mojon-Azzi SM, Sousa-Poza A, Mojon DS. Impact of low vision on well-being in 10 European countries. Ophthalmology. 2008;222(3):205–12. doi:10.1159/000126085.
   Google Scholar
• Demmin DL, Silverstein SM. Visual impairment and mental health: unmet needs and treatment options. Clin Ophthalmol. 2020;14:4229–4251. doi:10.2147/opth.S258783.
   PubMed Web of Science ®Google Scholar
• Nyman SR, Gosney MA, Victor CR. Psychosocial impact of visual impairment in working-age adults. Br J Ophthalmol. November 2010;94(11):1427–31. doi:10.1136/bjo.2009.164814.
   PubMed Web of Science ®Google Scholar
• Zhang X, Bullard KM, Cotch MF, et al. Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008. JAMA Ophthalmol. May 2013;131(5):573–81. doi:10.1001/jamaophthalmol.2013.2597.
   PubMed Web of Science ®Google Scholar
• Choi HG, Lee MJ, Lee SM. Visual impairment and risk of depression: a longitudinal follow-up study using a national sample cohort. Sci Rep. February 1, 2018;8(1):2083. doi:10.1038/s41598-018-20374-5.
   PubMedGoogle Scholar
• Brunes A, M BH, Heir T. Loneliness among adults with visual impairment: prevalence, associated factors, and relationship to life satisfaction. Health Qual Life Outcomes. February 1, 2019;17(1):24. doi:10.1186/s12955-019-1096-y.
   PubMedGoogle Scholar
• Hui MM, Wakefield D, Patel I, Cvejic E, McCluskey PJ, Chang JH. Visual functioning and health-related quality-of-life are compromised in patients with uveitis. Ocul Immunol Inflamm. August 2017;25(4):486–491. doi:10.3109/09273948.2016.1139734.
   PubMed Web of Science ®Google Scholar
• Fabiani C, Vitale A, Orlando I, et al. Impact of uveitis on quality of life: a prospective study from a tertiary referral rheumatology-ophthalmol collaborative uveitis center in Italy. Isr Med Assoc J. August 2017;19(8):478–483.
   PubMed Web of Science ®Google Scholar
• Shamdas M, Bassilious K, Murray PI. Health-related quality of life in patients with uveitis. Br J Ophthalmol. September 2019;103(9):1284–1288. doi:10.1136/bjophthalmol-2018-312882.
   PubMed Web of Science ®Google Scholar
• Prem Senthil M, Lim L, Braithwaite T, et al. The impact of adult uveitis on quality of life: an exploratory study. Ophthalmic Epidemiol. October 2021;28(5):444–452. doi:10.1080/09286586.2020.1856385.
   PubMed Web of Science ®Google Scholar
• Berlinberg EJ, Gonzales JA, Doan T, Acharya NR. Association between noninfectious uveitis and psychological stress. JAMA Ophthalmol. February 1, 2019;137(2):199–205. doi:10.1001/jamaophthalmol.2018.5893.
   PubMed Web of Science ®Google Scholar
• Grajewski RS, Boelke AC, Adler W, et al. Perceived Stress Levels in Adult Patients With Uveitis. Front Psychiatry. 2019;10:916. doi:10.3389/fpsyt.2019.00916.
   PubMed Web of Science ®Google Scholar
• Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. September 1996;80(9):844–8. doi:10.1136/bjo.80.9.844.
   PubMed Web of Science ®Google Scholar
• Stolk-Vos AC, Kasigar H, Nijmeijer KJ, et al. Outcomes in patients with chronic uveitis: which factors matter to patients? A qualitative study. BMC Ophthalmol. March 30, 2020;20(1):125. doi:10.1186/s12886-020-01388-y.
   PubMed Web of Science ®Google Scholar
• Tallouzi MO, Moore DJ, Bucknall N, et al. Outcomes important to patients with non-infectious posterior segment-involving uveitis: a qualitative study. BMJ Open Ophthalmol. 2020;5(1):e000481. doi:10.1136/bmjophth-2020-000481.
   PubMed Web of Science ®Google Scholar
• Kumar C. Psychosocial Well-Being of Individuals. In: Leal Filho W, Azul AM, Brandli L, Özuyar PG, Wall T, eds. Quality Education. Cham: Springer International Publishing; 2020:676–686.
   Google Scholar
• WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med. June 1998;46(12):1569–85. doi:10.1016/s0277-9536(98)00009-4.
   PubMed Web of Science ®Google Scholar
• Epstein RM, Street RL, Jr. The values and value of patient-centered care. Ann Fam Med. March-April 2011;9(2):100–3. doi:10.1370/afm.1239.
   PubMed Web of Science ®Google Scholar
• Dean S, Mathers JM, Calvert M, et al. “The patient is speaking”: discovering the patient voice in ophthalmol. Br J Ophthalmol. June 2017;101(6):700–708. doi:10.1136/bjophthalmol-2016-309955.
   PubMed Web of Science ®Google Scholar
• Black N. Patient reported outcome measures could help transform healthcare. Bmj. January 28, 2013;346:f167. doi:10.1136/bmj.f167.
   PubMedGoogle Scholar
• Weldring T, Smith SM. Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs). Health Serv Insights. 2013;6:61–8. doi:10.4137/hsi.S11093.
   PubMedGoogle Scholar
• U.S. Department of Health and Human Services FDA. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. October 11, 2006;4:79. doi:10.1186/1477-7525-4-79.
   PubMed Web of Science ®Google Scholar
• Jones L, Garway-Heath DF, Azuara-Blanco A, Crabb DP. Are patient self-reported outcome measures sensitive enough to be used as end points in clinical trials?: evidence from the United Kingdom glaucoma treatment study. Ophthalmology. May 2019;126(5):682–689. doi:10.1016/j.ophtha.2018.09.034.
   PubMed Web of Science ®Google Scholar
• Wallace S, Edmond J. In support of ophthalmol-specific patient-reported outcome measures. Ophthalmology. May 2019;126(5):690–691. doi:10.1016/j.ophtha.2018.12.007.
   PubMed Web of Science ®Google Scholar
• Braithwaite T, Calvert M, Gray A, Pesudovs K, Denniston AK. The use of patient-reported outcome research in modern Ophthalmol: impact on clinical trials and routine clinical practice. Patient Relat Outcome Meas. 2019;10:9–24. doi:10.2147/prom.S162802.
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Jacobsen G, Whitcup SM. Visual functioning and general health status in patients with uveitis. Arch Ophthalmol. June 2001;119(6):841–9.
   PubMed Web of Science ®Google Scholar
• Franke GH, Schutte E, Heiligenhaus A. Psychosomatik der Uveitis – eine Pilotstudie [Rehabilitation-psychological aspects of uveitis]. Psychother Psychosom Med Psychol. Febuary 2005;55(2):65–71.
   PubMed Web of Science ®Google Scholar
• Mello PR, Roma Ade C, Moraes Junior HV. Analise da qualidade de vida de portadores de uveites de causas infecciosas e nao infecciosas pelo questionario NEI-VFQ-25 [Analysis of the life quality of infectious and non-infectious patients with uveitis using the NEI-VFQ-25 questionnaire]. Arq Bras Oftalmol. November-December 2008;71(6):847–54.
   PubMed Web of Science ®Google Scholar
• Onal S, Savar F, Akman M, Kazokoglu H. Vision- and health-related quality of life in patients with behcet uveitis. Comparative study. Arch Ophthalmol. October 2010;128(10):1265–71. doi:10.1001/archophthalmol.2010.209.
   PubMedGoogle Scholar
• Frick KD, Drye LT, Kempen JH, et al. Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial. Comparative study multicenter study randomized controlled trial research support, n.i.h., extramural research support, non-U.S. Gov’t. Invest Ophthalmol Vis Sci. March 2012;53(3):1169–76. doi:10.1167/iovs.11-8259.
   PubMed Web of Science ®Google Scholar
• Qian Y, Glaser T, Esterberg E, Acharya NR. Depression and visual functioning in patients with ocular inflammatory disease. Research Support, N.I.H., extramural research support, non-U.S. Gov’t. Am J Ophthalmol. February 2012;153(2):370–378.e2. doi:10.1016/j.ajo.2011.06.028.
   PubMed Web of Science ®Google Scholar
• Tan P, Koh YT, Wong PY, Teoh SC. Evaluation of the impact of uveitis on visual-related quality of life. Comparative Study. Ocul Immunol Inflamm. December 2012;20(6):453–9. doi:10.3109/09273948.2012.723781.
   PubMed Web of Science ®Google Scholar
• Kuiper JJ, Missotten T, Baarsma SG, Rothova A. Vision-related quality of life in patients with birdshot chorioretinopathy. Letter. Acta Ophthalmol (Oxf). June 2013;91(4):e329–31. doi:10.1111/aos.12054.
   PubMed Web of Science ®Google Scholar
• Naik RK, Rentz AM, Foster CS, et al. Normative comparison of patient-reported outcomes in patients with noninfectious uveitis. Clinical Trial, phase iii comparative study multicenter study randomized controlled trial research support, non-U.S. Gov’t. JAMA Ophthalmol. February 2013;131(2):219–25. doi:10.1001/2013.jamaophthalmol.102.
   PubMed Web of Science ®Google Scholar
• Sakai T, Watanabe H, Kuroyanagi K, et al. Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis. Comparative Study. Br J Ophthalmol. March 2013;97(3):338–42. doi:10.1136/bjophthalmol-2012-302515.
   PubMed Web of Science ®Google Scholar
• Hoeksema L, Los LI. Vision-related quality of life in herpetic anterior uveitis patients. Research support, non-U.S. Gov’t. PLoS ONE. 2014;9(1):e85224. doi:10.1371/journal.pone.0085224.
   PubMed Web of Science ®Google Scholar
• Kaleemunnisha S, Sudharshan S, Biswas J. Quality of life in non-infectious uveitis patients on immunosuppressive therapy. Middle East Afr J Ophthalmol. July-September 2014;21(3):225–31. doi:10.4103/0974-9233.134675.
   PubMedGoogle Scholar
• Gui W, Dombrow M, Marcus I, et al. Quality of life in patients with noninfectious uveitis treated with or without systemic anti-inflammatory therapy. Ocul Immunol Inflamm. April 2015;23(2):135–43. doi:10.3109/09273948.2013.874445.
   PubMed Web of Science ®Google Scholar
• Butt GF, Poonit N, Wolffsohn J, Murray PI, Rauz S. Reading performance, using a novel app, and quality of life in patients with inflammatory eye disease. Conference abstract. Invest Ophthalmol Vis Sci. September 2016;57(12):5591.
   Web of Science ®Google Scholar
• Hoeksema L, Los LI. Vision-Related Quality of Life in Patients with Inactive HLA-B27-Associated-spectrum anterior uveitis. Research support, non-U.S. Gov’t. PLoS ONE. 2016;11(1):e0146956. doi:10.1371/journal.pone.0146956.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yan HG, Chi Y, Guo CY, Yang L. [Vision-and health-related quality of life in patients with uveitis]. Chung Hua Yen Ko Tsa Chih. June 11, 2016;52(6):429–36. doi:10.3760/cma.j.issn.0412-4081.2016.06.007.
   Google Scholar
• Greer LC, Jawed MF, Caldwell K, et al. Assessment of changes in quality of life among subjects in the STOP-uveitis study. Conference Abstract. Invest Ophthalmol Vis Sci Conf. 2017;58(8):2187.
   PubMedGoogle Scholar
• Haasnoot AJW, Sint Jago NFM, Tekstra J, de Boer JH. Impact of Uveitis on Quality of Life in Adult Patients With Juvenile Idiopathic Arthritis. Research Support, Non-U.S. Gov’t. Arthritis Care Res (Hoboken). 12 2017;69(12):1895–1902. doi:10.1002/acr.23224.
   PubMed Web of Science ®Google Scholar
• Arriola-Villalobos P, Abasolo L, Garcia-Feijoo J, et al. Vision-related quality of life in patients with non-infectious uveitis: a cross-sectional study. Ocul Immunol Inflamm. 2018;26(5):717–725. doi:10.1080/09273948.2017.1285034.
   PubMed Web of Science ®Google Scholar
• Onal S, Oray M, Yasa C, et al. Screening for depression and anxiety in patients with active uveitis. Ocul Immunol Inflamm. 2018;26(7):1078–1093. doi:10.1080/09273948.2017.1319959doi:
   PubMed Web of Science ®Google Scholar
• Verhagen FH, Wijnhoven R, Ossewaarde-van Norel J, et al. Prevalence and characteristics of ocular pain in non-infectious uveitis: a quality of life study. Br J Ophthalmol. 08 2018;102(8):1160–1166. doi:10.1136/bjophthalmol-2017-311575.
   PubMed Web of Science ®Google Scholar
• Silva LMP, Arantes TE, Casaroli-Marano R, Vaz T, Belfort R, Jr. Muccioli C. Quality of life and psychological aspects in patients with visual impairment secondary to uveitis: a clinical study in a tertiary care hospital in Brazil. Ocul Immunol Inflamm. 2019;27(1):99–107. doi:10.1080/09273948.2017.1370551.
   PubMed Web of Science ®Google Scholar
• Canamary AM, Jr., Monteiro IR, Machado Silva MKM, et al. Quality-of-life and psychosocial aspects in patients with ocular toxoplasmosis: a clinical study in a tertiary care hospital in Brazil. Observational study. Ocul Immunol Inflamm. May 18, 2020;28(4):679–687. doi:10.1080/09273948.2019.1612453.
   PubMed Web of Science ®Google Scholar
• Hernandez I, Abasolo L, Fernandez B, et al. Progression of vision-related quality of life and identification of risk factors in non-infectious uveitis patients. Conference Abstract. Ann Rheum Dis. June 2020;79(SUPPL 1):1217. doi:10.1136/annrheumdis-2020-eular.5889.
   Google Scholar
• Pleyer U, Almutairi S, Murphy C, et al. Impact of adalimumab (humira) therapy on ocular inflammation, selected health care resource utilization, and patient-reported outcomes in patients with active non-infectious intermediate, posterior, or panuveitis in routine clinical practice. Conference Abstract. Arthritis Rheumatol. October 2020;72(SUPPL 10):314–317. doi:10.1002/art.41538.
   Google Scholar
• Pohlmann D, Barth A, Macedo S, Pleyer U, Winterhalter S, Albayrak O. The impact of impending / onset of vision loss on depression, anxiety, and vision-related quality of life in birdshot-retinochoroiditis and serpiginous choroiditis. PLoS ONE. 2020;15(10):e0239210. doi:10.1371/journal.pone.0239210.
   PubMed Web of Science ®Google Scholar
• Arruda JSD, Tiburcio JD, de Campos-Carli SM, Teixeira AL, Vasconcelos-Santos DV. Vision-related quality of life and depression In Brazilian Patients with toxoplasmic retinochoroiditis: ocular toxoplasmosis, quality of life and depression. Int J Infect Dis. November 2021;112:66–72. doi:10.1016/j.ijid.2021.08.051.
   PubMed Web of Science ®Google Scholar
• Bertrand PJ, Jamilloux Y, Kodjikian L, et al. Quality of life in patients with uveitis: data from the ULISSE study (Uveitis: cLInical and medico-economic evaluation of a Standardised Strategy for the Etiological diagnosis). Multicenter study randomized controlled trial. Br J Ophthalmol. 07 2021;105(7):935–940. doi:10.1136/bjophthalmol-2020-315862.
   PubMed Web of Science ®Google Scholar
• Cimino L, Neri P, Miserocchi E, et al. Non-infectious uveitis burden on quality of life and work impairment assessed through different psychometric questionnaires. Eur J Ophthalmol. August 16, 2021:11206721211034649. doi:10.1177/11206721211034649.
   Web of Science ®Google Scholar
• Eser-Ozturk H, Yeter V, Karabekiroglu A, Sullu Y. The effect of vision-related quality of life on depression and anxiety in patients with behcet uveitis. Turk J Ophthalmol. December 28, 2021;51(6):358–364. doi:10.4274/tjo.galenos.2020.06791.
   PubMedGoogle Scholar
• Jin Y, Lin D, Dai ML, et al. Economic hardship, ocular complications, and poor self-reported visual function are predictors of mental problems in patients with uveitis. Ocul Immunol Inflamm. August 18, 2021;29(6):1045–1055. doi:10.1080/09273948.2020.1770297.
   PubMed Web of Science ®Google Scholar
• Kelly NK, Chattopadhyay A, Rathinam SR, et al. Health- and vision-related quality of life in a randomized controlled trial comparing methotrexate and mycophenolate mofetil for uveitis. comparative study multicenter study randomized controlled trial research support, n.i.h., extramural research support, non-U.S. Gov’t. Ophthalmology. 2021;128(9):1337–1345. doi:10.1016/j.ophtha.2021.02.024.
   PubMed Web of Science ®Google Scholar
• Li JQ, Dell J, Holler T, et al. Das Treatment Exit Options for Uveitis (TOFU) Register: Einbindung von Patienten in die Evidenzgenerierung. [The Treatment Exit Options for Uveitis (TOFU) Registry: Involving Patients in the Generation of Evidence]. Gesundheitswesen. November 2021;83(S 01):S39–S44. doi:10.1055/a-1630-6895.
   PubMedGoogle Scholar
• Sekaran A, Shamdas M, Barry RJ, Denniston AK, Murray PI. creating a health utility value for birdshot chorioretinopathy. Ocul Immunol Inflamm. January 02, 2022;30(1):73–80. doi:10.1080/09273948.2020.1799034.
   PubMed Web of Science ®Google Scholar
• Venkataraman A, Rathinam SR. A pre- and post-treatment evaluation of vision-related quality of life in uveitis. Validation Study. Indian J Ophthalmol. July-August 2008;56(4):307–12.
   PubMed Web of Science ®Google Scholar
• Tamrakar AR, Kharel Sitaula R, Joshi SN, Bajracharya M. Vision-related quality of life and psychosocial well-being of patients with episcleritis and scleritis: a neglected essence? J Ophthalmic Inflamm Infect. December 2021;11(1) (no pagination)34. doi:10.1186/s12348-021-00265-z.
   PubMed Web of Science ®Google Scholar
• Vakros G, Scollo P, Hodson J, Murray PI, Rauz S. Anxiety and depression in inflammatory eye disease: exploring the potential impact of topical treatment frequency as a putative psychometric item. BMJ Open Ophthalmol. 2021;6(1):e000649. doi:10.1136/bmjophth-2020-000649.
   PubMed Web of Science ®Google Scholar
• Gardiner AM, Armstrong RA, Dunne MC, Murray PI. Correlation between visual function and visual ability in patients with uveitis. Research Support, Non-U.S. Gov’t. Br J Ophthalmol. September 2002;86(9):993–6.
   PubMed Web of Science ®Google Scholar
• Murphy CC, Hughes EH, Frost NA, Dick AD. Quality of life and visual function in patients with intermediate uveitis. Research Support, non-U.S. Gov’t. Br J Ophthalmol. September 2005;89(9):1161–5.
   PubMed Web of Science ®Google Scholar
• Murphy CC, Greiner K, Plskova J, Frost NA, Forrester JV, Dick AD. Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis. Clinical trial, phase i clinical trial, phase ii randomized controlled trial research support, non-U.S. Gov’t. Br J Ophthalmol. February 2007;91(2):154–6.
   PubMedGoogle Scholar
• Jalil A, Yin K, Coyle L, Harper R, Jones NP. Vision-related quality of life and employment status in patients with uveitis of working age: a prospective study. Ocul Immunol Inflamm. August 2012;20(4):262–5. doi:10.3109/09273948.2012.684420.
   PubMed Web of Science ®Google Scholar
• Goodchild C, O’Rourke M, Haroon M, FitzGerald O, Murphy CC. 5-year longitudinal study of clinical and patient-reported outcomes in acute anterior uveitis. Observational Study. Eye. 02 2021;35(2):651–658. doi:10.1038/s41433-020-0937-6.
   PubMed Web of Science ®Google Scholar
• Miserocchi E, Modorati G, Mosconi P, Colucci A, Bandello F. Quality of life in patients with uveitis on chronic systemic immunosuppressive treatment. Ocul Immunol Inflamm. August 2010;18(4):297–304. doi:10.3109/09273941003637510.
   PubMed Web of Science ®Google Scholar
• Naik RK, Gries KS, Rentz AM, Kowalski JW, Revicki DA. Psychometric evaluation of the national eye institute visual function questionnaire and visual function questionnaire utility index in patients with non-infectious intermediate and posterior uveitis. Evaluation study. Qual Life Res. December 2013;22(10):2801–8. doi:10.1007/s11136-013-0412-y.
   PubMed Web of Science ®Google Scholar
• Mueller CM, Ward L, O’Keefe GAD. Health literacy, medication adherence, and quality of life in patients with uveitis. Ocul Immunol Inflamm. Mar 2021; 19:1–8. doi:10.1080/09273948.2020.1861304.
   Google Scholar
• Maca SM, Wagner J, Weingessel B, Vecsei-Marlovits PV, Gruber K, Schiesser AW. Acute anterior uveitis is associated with depression and reduction of general health. Comparative study. Br J Ophthalmol. March 2013;97(3):333–7. doi:10.1136/bjophthalmol-2012-302304.
   PubMed Web of Science ®Google Scholar
• Niemeyer KM, Gonzales JA, Doan T, Browne EN, Rao MM, Acharya NR. Time Trade-off Utility Values in Noninfectious Uveitis. Research support, N.I.H., extramural research support, Non-U.S. Gov’t. Am J Ophthalmol. 2019;208:47–55. doi:10.1016/j.ajo.2019.06.005.
   PubMed Web of Science ®Google Scholar
• Concha-del Rio LE, Cheja-Kalb R. Psychosocial and economic impact of uveitis in mexico. [Spanish]. Impacto psicosocial y economico de la uveitis en mexico. Gaceta Medica de Mexico. 2021;157(2):147–153. doi:10.24875/GMM.20000156.
   PubMedGoogle Scholar
• Maca SM, Schiesser AW, Sobala A, et al. Distress, depression and coping in HLA-B27-associated anterior uveitis with focus on gender differences. Research support, Non-U.S. Gov’t. Br J Ophthalmol. May 2011;95(5):699–704. doi:10.1136/bjo.2009.174839.
   PubMed Web of Science ®Google Scholar
• Sittivarakul W, Wongkot P. Anxiety and depression among patients with uveitis and ocular inflammatory disease at a tertiary center in southern thailand: vision-related quality of life, sociodemographics, and clinical characteristics associated. Ocul Immunol Inflamm. 2019;27(5):731–742. doi:10.1080/09273948.2018.1484495.
   PubMed Web of Science ®Google Scholar
• Mulholland B, Marks M, Lightman SL. Anterior uveitis and its relation to stress. Br J Ophthalmol. October 2000;84(10):1121–4.
   PubMed Web of Science ®Google Scholar
• Abdel-Aty A, Kombo N. The Association Between Mental Health Disorders and Non-Infectious Scleritis: A Prevalence Study and Review of the Literature. Eur J Ophthalmol. December 16, 2021:11206721211067652. doi:10.1177/11206721211067652.
   Web of Science ®Google Scholar
• De-La-Torre Cifuentes A, De Mesa CL, Lince LAF, Criollo-Porras E, Palacios-Espinosa X, Duran F. Coping strategies in adult patients with uveitis in Colombia. Conference abstract. Invest Ophthalmol Vis Sci conf. 2017;58(8):2152.
   PubMed Web of Science ®Google Scholar
• Thorne JE, Tundia N, Skup M, et al. Direct and indirect resource use and costs associated with non-infectious non-anterior uveitis. Conference abstract. Invest Ophthalmol Vis Sci. April 2014;55(13):5320.
   PubMed Web of Science ®Google Scholar
• Yu T, Holbrook JT, Thorne JE, Flynn TN, Van Natta ML, Puhan MA. Outcome preferences in patients with noninfectious uveitis: results of a best-worst scaling study. journal article; multicenter study; randomized controlled trial; research support, N.I.H., Extramural. Invest Ophthalmol Vis Sci. 2015;56(11):6864–6872. doi:10.1167/iovs.15-16705.
   Web of Science ®Google Scholar
• Angeles-Han ST, Yeh S, McCracken C, et al. Using the effects of youngsters’ eyesight on quality of life questionnaire to measure visual outcomes in children with uveitis. research support, N.I.H., extramural research support, non-U.S. Gov’t. Arthritis Care Res (Hoboken). November 2015;67(11):1513–20. doi:10.1002/acr.22627.
   PubMed Web of Science ®Google Scholar
• Angeles-Han ST, Griffin KW, Harrison MJ, et al. Development of a vision-related quality of life instrument for children ages 8-18 years for use in juvenile idiopathic arthritis-associated uveitis. Research support, N.I.H., extramural research support, non-U.S. Gov’t validation study. Arthritis Care Res (Hoboken). September 2011;63(9):1254–61. doi:10.1002/acr.20524.
   PubMed Web of Science ®Google Scholar
• Ezzahri M, Amine B, Rostom S, et al. The uveitis and its relationship with disease activity and quality of life in Moroccan children with juvenile idiopathic arthritis. Clin Rheumatol. September 2013;32(9):1387–91. doi:10.1007/s10067-013-2262-y.
   PubMed Web of Science ®Google Scholar
• Beretta GB, Minoia F, Marelli L, et al. Visual function and quality of life: a cross-sectional study on a cohort of juvenile idiopathic arthritis-associated and idiopathic uveitis. Conference abstract. Pediatric Rheumatology Conference: 27th European Paediatric Rheumatology Congress, PReS. 2021;19(SUPPL 1). doi:10.1186/s12969-021-00632-z
   Google Scholar
• McDonald J, Cassedy A, Altaye M, et al. Comprehensive assessment of quality of life, functioning and mental health in children with juvenile idiopathic arthritis and non-infectious uveitis. Arthritis Care Res (Hoboken). January 09, 2021;09:09. doi:10.1002/acr.24551.
   Google Scholar
• Utz VM, Cassedy A, Hennard T, Mwase N, Angeles-Han S. Responsiveness of quality of life and function assessment to changes in topical eye medications in children with uveitis. Conference abstract. Arthritis Rheumatol. September 2021;73(SUPPL 9):3373–3374. doi:10.1002/art.41966.
   Google Scholar
• Cassedy A, Altaye M, Andringa J, et al. Assessing the validity and reliability of the effects of youngsters’ eyesight on quality of life questionnaire among children with uveitis. Multicenter study research support, N.I.H., extramural, research support, non-U.S. Gov’t validation study. Arthritis Care Res (Hoboken). 2022;74(3):355–363. doi:10.1002/acr.24491.
   PubMed Web of Science ®Google Scholar
• Fondriest J, Cassedy A, Hennard T, et al. Assessing visual function and quality of life in children with jia and jia-uveitis younger than 7 years old. Conference abstract. Investigative Ophthalmology & Visual Science confrence: Annual Meeting Association for Research in Vision and Ophthalmol, ARVO. 2021;62(8)
   Google Scholar
• Maca SM, Amirian A, Prause C, Gruber K, Mejdoubi L, Barisani-Asenbauer T. Understanding the impact of uveitis on health-related quality of life in adolescents. Acta Ophthalmol (Oxf). May 2013;91(3):e219–24. doi:10.1111/aos.12016.
   PubMed Web of Science ®Google Scholar
• Bottner K, Mussinghoff P, Meyer Zur Horste M, Heinz C, Heiligenhaus A. Sozialmedizinische Folgen bei Uveitis im Kindes- und Jugendalter: Ergebnisse einer Pilotstudie. [Social medical consequences of uveitis in childhood and adolescence: results of a pilot study]. Klin Monatsbl Augenheilkd. September 2017;234(9):1174–1178. doi:10.1055/s-0042-120276.
   PubMedGoogle Scholar
• Howsley P, Dunkley L, Calvert R, et al. Psychosocial factors associated with transition readiness in adolescents and young adults with uveitis. Conference abstract. Rheumatol (UK). October 2018;57(Supplement 8):viii24. doi:10.1093/rheumatology/key273.054.
   Google Scholar
• Wieringa WG, van Berkel RJ, Los LI, Lelieveld O, Armbrust W. Physical and psychosocial health in pediatric uveitis patients. Ocul Immunol Inflamm. July 06, 2021:1–9. doi:10.1080/09273948.2021.1934484.
   PubMed Web of Science ®Google Scholar
• Sestan M, Grguric D, Sedmak M, et al. Quality of life in children suffering from juvenile idiopathic arthritis-associated uveitis. Rheumatol Int. July 2020;40(7):1117–1121. doi:10.1007/s00296-020-04536-1.
   PubMed Web of Science ®Google Scholar
• Barry JA, Folkard A, Denniston AK, Moran E, Ayliffe W. Development and validation of quality-of-life questionnaires for birdshot chorioretinopathy. Validation Study. Ophthalmology. July 2014;121(7):1488–9.e2. doi:10.1016/j.ophtha.2014.01.007.
   PubMed Web of Science ®Google Scholar
• Vigil EM, Sepah YJ, Watters AL, et al. Assessment of changes in quality of life among patients in the SAVE study - sirolimus as therapeutic approach to uVEitis: a randomized study to assess the safety and bioactivity of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis. J Ophthalmic Inflamm Infect. 2015;5:13. doi:10.1186/s12348-015-0044-1.
   PubMedGoogle Scholar
• Sugar EA, Venugopal V, Thorne JE, et al. Longitudinal vision-related quality of life for patients with noninfectious uveitis treated with fluocinolone acetonide implant or systemic corticosteroid therapy. Comparative study multicenter study randomized controlled trial research support, non-U.S. Gov’t. Ophthalmology. 2017;124(11):1662–1669. doi:10.1016/j.ophtha.2017.05.015.
   PubMed Web of Science ®Google Scholar
• Sugar EA, Burke AE, Venugopal V, et al. Responsiveness of vision-specific and general quality of life metrics to ocular and systemic events in patients with uveitis. Comparative study research support, n.i.h., extramural. Ophthalmology. 2020;127(12):1710–1718. doi:10.1016/j.ophtha.2020.07.038.
   PubMedGoogle Scholar
• An JX, Wang Y, Cope DK, Williams JP. Quantitative evaluation of pain with pain index extracted from electroencephalogram. Chin Med J (Engl). August 20, 2017;130(16):1926–1931. doi:10.4103/0366-6999.211878.
   PubMed Web of Science ®Google Scholar
• Mangione CM, Berry S, Spritzer K, et al. Identifying the content area for the 51-item national eye institute visual function questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol. February 1998;116(2):227–33. doi:10.1001/archopht.116.2.227.
   PubMedGoogle Scholar
• Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item national eye institute visual function questionnaire. Arch Ophthalmol. July 2001;119(7):1050–8. doi:10.1001/archopht.119.7.1050.
   PubMed Web of Science ®Google Scholar
• Klein R, Moss SE, Klein BE, Gutierrez P, Mangione CM. The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol. May 2001;119(5):733–40. doi:10.1001/archopht.119.5.733.
   PubMedGoogle Scholar
• Marella M, Pesudovs K, Keeffe JE, O’Connor PM, Rees G, Lamoureux EL. The psychometric validity of the NEI VFQ-25 for use in a low-vision population. Invest Ophthalmol Vis Sci. June 2010;51(6):2878–84. doi:10.1167/iovs.09-4494.
   PubMed Web of Science ®Google Scholar
• Orr P, Rentz AM, Margolis MK, et al. Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. Invest Ophthalmol Vis Sci. May 18, 2011;52(6):3354–9. doi:10.1167/iovs.10-5645.
   PubMed Web of Science ®Google Scholar
• Wan Y, Zhao L, Huang C, et al. Validation and comparison of the National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25) and the Visual Function Index-14 (VF-14) in patients with cataracts: a multicentre study. Acta Ophthalmol. June 2021;99(4):e480–e488. doi:10.1111/aos.14606.
   PubMed Web of Science ®Google Scholar
• Frost NA, Sparrow JM, Durant JS, Donovan JL, Peters TJ, Brookes ST. Development of a questionnaire for measurement of vision-related quality of life. Ophthalmic Epidemiol. December 1998;5(4):185–210. doi:10.1076/opep.5.4.185.4191.
   PubMedGoogle Scholar
• Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. June 1992;30(6):473–83.
   PubMed Web of Science ®Google Scholar
• Ware JE, Jr., Gandek B. Overview of the SF-36 health survey and the International Quality of Life Assessment (IQOLA) project. J Clin Epidemiol. November 1998;51(11):903–12. doi:10.1016/s0895-4356(98)00081-x.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Qu B, Lun SS, Guo Y, Liu J. The 36-item short form health survey: reliability and validity in Chinese medical students. Int J Med Sci. 2012;9(7):521–6. doi:10.7150/ijms.4503.
   PubMed Web of Science ®Google Scholar
• WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL group. Psychol Med. May 1998;28(3):551–8. doi:10.1017/s0033291798006667.
   PubMed Web of Science ®Google Scholar
• Huang IC, Wu AW, Frangakis C. Do the SF-36 and WHOQOL-BREF measure the same constructs? Evidence from the Taiwan population*. Qual Life Res. February 2006;15(1):15–24. doi:10.1007/s11136-005-8486-9.
   PubMed Web of Science ®Google Scholar
• Castro PC, Driusso P, Oishi J. Convergent validity between SF-36 and WHOQOL-BREF in older adults. Rev Saude Publica. February 2014;48(1):63–7. doi:10.1590/s0034-8910.2014048004783.
   PubMed Web of Science ®Google Scholar
• Hsiung PC, Fang CT, Chang YY, Chen MY, Wang JD. Comparison of WHOQOL-bREF and SF-36 in patients with HIV infection. Qual Life Res. February 2005;14(1):141–50. doi:10.1007/s11136-004-6252-z.
   PubMed Web of Science ®Google Scholar
• Abbasi-Ghahramanloo A, Soltani-Kermanshahi M, Mansori K, et al. Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes. Int J Gen Med. 2020;13:497–506. doi:10.2147/ijgm.S258953.
   PubMed Web of Science ®Google Scholar
• Najafi M, Sheikhvatan M, Montazeri A, Abbasi SH, Sheikhfathollahi M. Quality of Life in Coronary Artery Disease: SF-36 Compared to WHOQOL-BREF. J Tehran Univ Heart Cent. January 01, 2008;3(2)
   Google Scholar
• Najafi M, Sheikhvatan M, Montazeri A, Sheikhfathollahi M. Reliability of World Health Organization’s Quality of Life-BREF versus short form 36 health survey questionnaires for assessment of quality of life in patients with coronary artery disease. J Cardiovasc Med (Hagerstown). April 2009;10(4):316–21. doi:10.2459/JCM.0b013e328326291a.
   PubMed Web of Science ®Google Scholar
• Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40(6):593–603. doi:10.1016/0021-9681(87)90019-1.
   PubMedGoogle Scholar
• Jones MB. Health status indexes: the trade-off between quantity and quality of life. Socioecon Plann Sci. 1977;11(6):301–5. doi:10.1016/0038-0121(77)90015-5.
   PubMed Web of Science ®Google Scholar
• Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA. October16, 1996 1996;276(15):1253–1258. In File.
   PubMed Web of Science ®Google Scholar
• Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. February 1999;37(2):126–39. doi:10.1097/00005650-199902000-00003.
   PubMed Web of Science ®Google Scholar
• Nickels S, Schuster AK, Singer S, et al. The National Eye Institute 25-Item Visual Function Questionnaire (NEI VFQ-25) - reference data from the German population-based Gutenberg Health Study (GHS). Health Qual Life Outcomes. August 8, 2017;15(1):156. doi:10.1186/s12955-017-0732-7.
   PubMedGoogle Scholar
• Von Der Heyde R. Chapter 6 - assessment of functional outcomes. In: Cooper C, ed. Fundamentals of Hand Therapy. Mosby; 2007:98–113.
   Google Scholar
• Varni JW. PedsQL translations. https://www.pedsql.org/translations.html
   Google Scholar
• Tallouzi MO, Mathers JM, Moore DJ, et al. Development of a core outcome set for clinical trials in non-infectious uveitis of the posterior segment. Research support, non-U.S. Gov’t. Ophthalmology. 08 2021;128(8):1209–1221. doi:10.1016/j.ophtha.2021.01.022.
   PubMed Web of Science ®Google Scholar
• Yuzawa M, Fujita K, Tanaka E, Wang EC. Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice. Clin Ophthalmol. 2013;7:1325–32. doi:10.2147/opth.S45248.
   PubMedGoogle Scholar
• Lahiri S, Sumodhee D, Alkarmi K, Pontikos N, Petrushkin H, Gilbert R. Exploring the potential for acute anterior uveitis (AAU) patients to self-manage recurrences via a mobile application: qualitative analysis of a moorfields patient experience focus group. Letter. Eye (Basingstoke). October 2021;35(10):2895–2896. doi:10.1038/s41433-020-01190-6.
   PubMedGoogle Scholar
• Compeyrot-Lacassagne S, Twoney C, Petrushkin H, et al. “Bothering to listen”: enabling patient and family involvement in childhood uveitis healthcare. Conference abstract. Ann Rheum Dis. June 2019;78(Supplement 2):557. doi:10.1136/annrheumdis-2019-eular.7262.
   Google Scholar